Juvenile psoriatic arthritis
Also known as: Psoriatic Arthritis, Juvenile / Oligoarthritis, Juvenile / Juvenile psoriatic arthritis (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09029 | Secukinumab | An immunomodulating agent and interleukin antagonist used to manage plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, along with other joint inflammatory disorders. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB09029 | Secukinumab | Interleukin-17A | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB05679 | Ustekinumab | 1 | Completed | 1 |
| DB00051 | Adalimumab | 3 | Active Not Recruiting | 1 |
| DB00051 | Adalimumab | 3 | Recruiting | 1 |
| DB05676 | Apremilast | 3 | Recruiting | 1 |
| DB02325 | Isopropyl alcohol | 3 | Recruiting | 1 |
| DB11569 | Ixekizumab | 3 | Active Not Recruiting | 1 |
| DB14762 | Risankizumab | 3 | Recruiting | 1 |
| DB09029 | Secukinumab | 3 | Active Not Recruiting | 1 |
| DB09029 | Secukinumab | 3 | Completed | 1 |
| DB08895 | Tofacitinib | Not Available | Not Yet Recruiting | 1 |